Revised EU Annex 1 2023 I Environmental Monitoring in pharmaceutical industry I cleanroom monitoring

Описание к видео Revised EU Annex 1 2023 I Environmental Monitoring in pharmaceutical industry I cleanroom monitoring

Learn how to perform Environmental monitoring of clean room as per Revised EU Annex 1 I Non - Viable monitoring of clean room I Viable Monitoring of clean room.

#Environmentalmonitoring #Viablemonitoring #Nonviable #cleanroommonitoring #cleanroom #EUAnnex1 #2023 #investigation #EM #revisedEUAnnex1

Welcome to GMPInsights, your go-to channel for pharmaceutical regulations! We provide comprehensive knowledge on regulations to empower professionals, covering global updates, compliance strategies, GMP, submissions, drug safety, challenges, and expert interviews. Join our community for regulatory enlightenment!

In this Video, we are going to take you through Environmental monitoring as per EU Annex - 1.

Please like, subscribe and share our videos.
Thank you for watching video.

Below are link for some relevant videos. Click to watch.
Media Fill / Aseptic Process Simulation :    • Media fill validation as per EU Annex...  
21 CFR Part 11 (Sub Part A) :    • 21 CFR Part 11 (Sub Part A) I 21 CFR ...  
21 CFR Part 11 (Sub Part B) :    • 21 CFR Part 11 (Sub Part B) I 21 CFR ...  
21 CFR Part 11 (Sub Part B) :    • 21 CFR Part 11 (Sub Part C) I 21 CFR ...  
CAPA Management:    • CAPA Management I Corrective and Prev...  
ICH Q10:    • ICH Q10 I Pharmaceutical Quality Syst...  
ICH Q9:    • ICH Guideline II Risk Assessment II I...  
GMP:    • Good Manufacturing Practices I Good m...  
Change Control Management:    • Change Control Management and Impleme...  


Disclaimer: The content of this video is intended for educational purposes only. The mention of any organization names, trademarks, or logos is solely for educational and informational purposes and does not imply any affiliation, endorsement, or sponsorship by any organizations.

Copyright disclaimer:
“Any illegal reproduction of this content will result in immediate legal action.”

Комментарии

Информация по комментариям в разработке